Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
- PMID: 29313490
- PMCID: PMC5760205
- DOI: 10.7554/eLife.30274
Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
Abstract
As part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Blum et al., 2015), that described how we intended to replicate selected experiments from the paper 'Transcriptional amplification in tumor cells with elevated c-Myc' (Lin et al., 2012). Here we report the results. We found overexpression of c-Myc increased total levels of RNA in P493-6 Burkitt's lymphoma cells; however, while the effect was in the same direction as the original study (Figure 3E; Lin et al., 2012), statistical significance and the size of the effect varied between the original study and the two different lots of serum tested in this replication. Digital gene expression analysis for a set of genes was also performed on P493-6 cells before and after c-Myc overexpression. Transcripts from genes that were active before c-Myc induction increased in expression following c-Myc overexpression, similar to the original study (Figure 3F; Lin et al., 2012). Transcripts from genes that were silent before c-Myc induction also increased in expression following c-Myc overexpression, while the original study concluded elevated c-Myc had no effect on silent genes (Figure 3F; Lin et al., 2012). Treating the data as paired, we found a statistically significant increase in gene expression for both active and silent genes upon c-Myc induction, with the change in gene expression greater for active genes compared to silent genes. Finally, we report meta-analyses for each result.
Keywords: Reproducibility Project: Cancer Biology; biochemistry; c-Myc; cancer biology; gene expression; human; metascience; replication; reproducibility.
Conflict of interest statement
Bioexpression and Fermentation Facility, University of Georgia is a Science Exchange associated lab.
Deep Sequencing and Microarray Core Facility, Johns Hopkins University is a Science Exchange associated lab.
No competing interests declared.
EI, RT, NP: Employed by and hold shares in Science Exchange Inc.
Figures
Comment in
-
Getting to grips with c-Myc.Elife. 2018 Jan 9;7:e32010. doi: 10.7554/eLife.32010. Elife. 2018. PMID: 29313487 Free PMC article.
-
Pioneering 'live-code' article allows scientists to play with each other's results.Nature. 2019 Mar;567(7746):17-18. doi: 10.1038/d41586-019-00724-7. Nature. 2019. PMID: 30837722 No abstract available.
Similar articles
-
Registered report: transcriptional amplification in tumor cells with elevated c-Myc.Elife. 2015 Jan 26;4:e04024. doi: 10.7554/eLife.04024. Elife. 2015. PMID: 25621564 Free PMC article.
-
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.Elife. 2017 Jan 19;6:e21253. doi: 10.7554/eLife.21253. Elife. 2017. PMID: 28100400 Free PMC article.
-
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8164-9. doi: 10.1073/pnas.1332764100. Epub 2003 Jun 13. Proc Natl Acad Sci U S A. 2003. PMID: 12808131 Free PMC article.
-
Role of Epstein-Barr virus in Burkitt's lymphoma.Curr Top Microbiol Immunol. 2001;258:141-51. doi: 10.1007/978-3-642-56515-1_9. Curr Top Microbiol Immunol. 2001. PMID: 11443859 Review.
-
Molecular biology of Burkitt's lymphoma.J Clin Oncol. 2000 Nov 1;18(21):3707-21. doi: 10.1200/JCO.2000.18.21.3707. J Clin Oncol. 2000. PMID: 11054444 Review.
Cited by
-
Integrative Approaches to Cancer Immunotherapy.Trends Cancer. 2019 Jul;5(7):400-410. doi: 10.1016/j.trecan.2019.05.010. Trends Cancer. 2019. PMID: 31311655 Free PMC article. Review.
-
Targeting c-Myc with a novel Peptide Nuclear Delivery Device.Sci Rep. 2020 Oct 20;10(1):17762. doi: 10.1038/s41598-020-73998-x. Sci Rep. 2020. PMID: 33082422 Free PMC article.
-
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.Signal Transduct Target Ther. 2024 Aug 21;9(1):205. doi: 10.1038/s41392-024-01907-z. Signal Transduct Target Ther. 2024. PMID: 39164274 Free PMC article. Review.
-
Publishing computational research - a review of infrastructures for reproducible and transparent scholarly communication.Res Integr Peer Rev. 2020 Jul 14;5:10. doi: 10.1186/s41073-020-00095-y. eCollection 2020. Res Integr Peer Rev. 2020. PMID: 32685199 Free PMC article. Review.
-
ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.Sci Adv. 2024 Mar 8;10(10):eadj8803. doi: 10.1126/sciadv.adj8803. Epub 2024 Mar 8. Sci Adv. 2024. PMID: 38457494 Free PMC article.
References
-
- Cohen J. The cost of dichotomization. Applied Psychological Measurement. 1983;7:249–253. doi: 10.1177/014662168300700301. - DOI
-
- Duffy DJ, Krstic A, Halasz M, Schwarzl T, Fey D, Iljin K, Mehta JP, Killick K, Whilde J, Turriziani B, Haapa-Paananen S, Fey V, Fischer M, Westermann F, Henrich K-O, Bannert S, Higgins DG, Kolch W. Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma. Oncotarget. 2015;6:43182–43201. doi: 10.18632/oncotarget.6568. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
